The potential to backfill in phase I trials: the National Cancer Institute's Cancer Therapy Evaluation Program experience.

Foster, Jared C; Korn, Edward L; Freidlin, Boris; Moscow, Jeffrey A

The potential to backfill in phase I trials: the National Cancer Institute's Cancer Therapy Evaluation Program experience.

Foster, Jared C; Korn, Edward L; Freidlin, Boris; Moscow, Jeffrey A.

Afiliação

Foster JC; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Korn EL; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Freidlin B; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Moscow JA; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.

JNCI Cancer Spectr ; 7(6)2023 10 31.

Article em En | MEDLINE | ID: mdl-38001028

Assuntos

Neoplasias; Projetos de Pesquisa; Estados Unidos; Humanos; National Cancer Institute (U.S.); Neoplasias/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Neoplasias Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: JNCI Cancer Spectr Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google